Subcutaneous Immunoglobulin in Chronic Inflammatory Demyelinating Polyneuropathy

    loading  Checking for direct PDF access through Ovid

Abstract

Synopsis:

Subcutaneous immunoglobulin appears to be an effective treatment alternative to intravenous immunoglobulin for patients with chronic inflammatory demyelinating polyneuropathy.

Source:

Markvadsen LH, et al, for The Danish CIDP and MMN Study Group. Subcutaneous immunoglobulin in responders to intravenous therapy with chronic inflammatory demyelinating polyradiculoneuropathy. Eur J Neurol 2013;20:836-842.

Related Topics

    loading  Loading Related Articles